Circulating microRNA expressions can predict the outcome of lenalidomide plus low-dose dexamethasone treatment in patients with refractory/relapsed multiple myeloma.

ABSTRACT:

SUBMITTER: Jung SH 

PROVIDER: S-EPMC5664408 | biostudies-literature | 2017 Nov

REPOSITORIES: biostudies-literature